Skip to search.
 TSX Down 0.40% TSX Ventures Up 0.34%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
17.44 Mar 26, 4:00PM EDT
Add to Portfolio
Prev Close:17.44
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:23.50
Beta:0.25
Earnings Date:May 11 - May 15 (Est.)
Day's Range:N/A - N/A
52wk Range:11.80 - 18.86
Volume:0
Avg Vol (3m):143,987
Market Cap:599.10M
P/E (ttm):N/A
EPS (ttm):-0.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OSIR 0.00%599.10M
ABT70.17B
BIIB100.63B

Key Statistics

Forward P/E (1 yr):29.07
P/S (ttm):10.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.31
Quarterly EPS Est (Mar-15) :0.00
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback